Memorial Sloan-Kettering investigators have developed a personalized tool to help women and their doctors predict overall survival at five years after a diagnosis of uterine leiomyosarcoma.

For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease.

Two Memorial Sloan-Kettering studies provide new clues about genetic mutations that affect cell behavior and play a role in several types of cancer.

Soon after Halina Frydman’s husband noticed changes in his wife's personality, Halina was diagnosed with primary central nervous system lymphoma. She came to Memorial Sloan-Kettering to receive treatment through a clinical trial.

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.